Badly engineered fibrillin: Lessons from molecular studies of Marfan syndrome

Trends in Cardiovascular Medicine

Volumn 7, Issue 8, 1997, Pages 282-288

  Rantamäki, Terhi ^a   Karttunen, Leena ^a   Peltonen, Leena ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; FIBRILLIN;

CARDIOVASCULAR DISEASE; CONNECTIVE TISSUE DISEASE; EXTRACELLULAR MATRIX; GENE MUTATION; GENETIC ENGINEERING; HUMAN; MARFAN SYNDROME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW;

EID: 0343471396     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00087-X     Document Type: Review

References (46)

1. Abrams WR, Ma R-I, Kucich U, et al: 1995. Molecular cloning of the microfibrillar protein MFAP3 and assignment of the gene to human chromosome 5q32-q33.2. Genomics 26:47-54.
2. Aoyama T, Francke U, Dietz HC, Furthmayr H: 1994. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J Clin Invest 94:130-137.
3. Beighton P, de Paepe A, Danks D, et al.: 1988. International nosology of heritable disorders of connective tissue, Berlin, 1986. Am J Med Genet 29:581-594.
4. Collod G, Babron M-C, Jondeau G, et al.: 1994. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet 8:264-268.
5. Collod-Béroud G, Béroud C, Adès L, et al.: 1997. Marfan database (second edition): software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Res 25:147-150.
6. Corson GM, Chalberg SC, Dietz HC, Charbonneau NL, Sakai LY: 1993. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5' end. Genomics 17: 476-484.
7. Curran ME, Atkinson DL, Ewart AK, Morris CA, Leppert MF, Keating MT: 1993. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell 73:159-168.
8. Danks DM: 1993. Disorders of copper transport: Menkes disease and the occipital horn syndrome. In Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders, 1st ed. New York, Wiley-Liss, Inc., pp 487-505.
9. De Paepe A, Devereux RB, Dietz HC, Hennekam RCM, Pyeritz RE: 1996. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417-426.
10. Dietz HC, Pyeritz RE: 1995. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet 4:1799-1809.
11. Dietz HC, Cutting GR, Pyeritz RE, et al.: 1991. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337-339.
12. Downing AK, Knott V, Werner JM, Cardy CM, Campbell ID, Handford PA: 1996. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 85:597-605.
13. Edwards MJ, Wenstrup RJ, Byers PH, Cohn DH: 1992. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen: the mosaic parent exhibits phenotypic features of a mild form of the disease. Hum Mutat 1:47-54.
14. Geva T, Sanders SP, Diogenes MS, Rockenmacher S, Van Praagh R: 1990. Two-dimensional and doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome. Am J Cardiol 65:1230-1237.
15. Gibson MA, Hatzinikolas G, Kumaratilake JS, et al.: 1996. Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of MAGP-2 (MP25). J Biol Chem 271:1096-1103.
16. Handford P, Downing AK, Rao Z, Hewett DR, Sykes BC, Kielty CM: 1995. The calcium binding properties and molecular organization of epidermal growth factor-like domains in human fibrillin-1. J Biol Chem 270:6751-6756.
17. Hayward C, Porteous MEM, Brock DJH: 1994. A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly. Mol Cell Probe 8:325-327.
18. Hollister DW, Godfrey M, Sakai LY, Pyeritz RE: 1990. Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N Engl J Med 323:152-159.
19. Ikegawa S, Toda T, Okui K, Nakamura Y: 1996. Structure and chromosomal assignment of the human S1-5 gene (FBNL) that is highly homologous to fibrillin. Genomics 35:590-592.
20. Kainulainen K, Pulkkinen L, Savolainen A, Kaitila I, Peltonen L: 1990. Location on chromosome 15 of the gene defect causing Marfan syndrome. N Engl J Med 323:935-939.
21. Kainulainen K, Steinmann B, Collins E et al.: 1991. Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene. Am J Hum Genet 49:662-667.
22. Karttunen L, Lönnqvist L, Godfrey M, Peltonen L, Syvänen A-C: 1996. An accurate method for comparing transcript levels of two alleles or highly homologous genes: application to fibrillin transcripts in Marfan patients' fibroblasts. Genome Res 6:392-403.
23. Kielty CM, Shuttleworth CA: 1993. The role of calcium in the organization of fibrillin microfibrils. FEBS Lett 336:323-326.
24. Kivirikko KJ: 1993. Collagens and their abnormalities in a wide spectrum of diseases. Ann Med 25:113-126.
25. Lee B, Godfrey M, Vitale E, et al.: 1991. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 352:330-334.
26. Lönnqvist L, Child A, Kainulainen K, Davidson R, Puhakka L, Peltonen L: 1994. A novel mutation of the fibrillin gene causing ectopia lentis. Genomics 19:573-576.
27. Lönnqvist L, Karttunen L, Rantamäki T, Kielty C, Raghunath M, Peltonen L: 1996. A point mutation creating an extra N-glycosylation site in fibrillin-1 results in neonatal Marfan syndrome. Genomics 36:468-475.
28. Milewicz DM, Pyeritz RE, Crawford ES, Byers PH: 1992. Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J Clin Invest 89:79-86.
29. Milewicz DM, Grossfield J, Cao S-N, Kielty C, Covitz W, Jewett T: 1995. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest 95:2373-2378.
30. Pereira L, Ramirez R: 1996. Two fibrillins and one or many microfibrils? [abst]. Eur J Pediatr 155:732.
31. Pereira L, D'Alessio M, Ramirez F, et al.: 1993. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet 2:961-968.
32. Pereira L, Levran O, Ramirez F, et al.: 1994. A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. N Engl J Med 331:148-153.
33. Putnam EA, Zhang H, Ramirez F, Milewicz DM: 1995. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat Genet 11: 456-458.
34. Putnam EA, Cho M, Zinn AB, Towbin JA, Byers PH, Milewicz DM: 1996. Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet 62:233-242.
35. Pyeritz RE: 1993. The Marfan syndrome. In Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders, 1st ed. New York, Wiley-Liss, Inc., pp 437-468.
36. Rantamäki T, Lönnqvist L, Karttunen L, Kainulainen K, Peltonen L: 1994. DNA diagnostics of the Marfan syndrome: application of amplifiable polymorphic markers. Eur J Hum Genet 2:66-75.
37. Reinhardt DP, Keene DR, Corson GM, et al.: 1996. Fibrillin-1: organization in microfibrils and structural properties. J Mol Biol 258: 104-116.
38. Reinhardt DP, Ono RN, Sakai LY: 1997. Calcium stabilizes fibrillin-1 against proteolytic degradation. J Biol Chem 272:1231-1236.
39. Rosenbloom J, Abrams WR, Mecham R: 1993. Extracellular matrix 4: the elastic fiber. FASEB J 7:1208-1218.
40. Sakai LY, Keene DR, Engvall E: 1986. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103: 2499-2509.
41. Wang M, Kishnani P, Decker-Phillips M, Kahler SG, Chen Y-T, Godfrey M: 1996. Double mutant fibrillin-1 (FBN1) allele in a patient with neonatal Marfan syndrome. J Med Genet 33: 760-763.
42. Yeh H, Chow M, Abrams WR, et al: 1994. Structure of the human gene encoding the associated microfibrillar protein (MFAP1) and localization to chromosome 15q15-q21. Genomics 23:443-449.
43. Yin W, Smiley E, Germiller J, et al.: 1995. Primary structure and developmental expression of Fbnl, the mouse fibrillin gene. J Biol Chem 270:1798-1806.
44. Zhang H, Apfelroth SD, Hu W, et al.: 1994. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol 124:855-863.
45. Zhang H, Hu W, Ramirez F: 1995. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol 129:1165-1176.
46. Zhao Z, Lee C-C, Jiralerspong S, et al.: 1995. The gene for a human microfibril-associated glycoprotein is commonly deleted in Smith-Magenis syndrome patients. Hum Mol Genet 4:589-597.